Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Sunisa Prasopporn; Orawan Suppramote; Ben Ponvilawan; Chanette Jamyuang; Jantappapa Chanthercrob; Amphun Chaiboonchoe; Pimkanya More-Krong; Kamonchanok Kongsri; Monthira Suntiparpluacha; Rawisak Chanwat; Krittiya Korphaisarn; Seiji Okada; Somponnat Sampattavanich; Siwanon Jirawatnotai

doi:10.3389/fonc.2022.1124912

Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma

Front Oncol. 2023 Jan 6:12:1124912. doi: 10.3389/fonc.2022.1124912. eCollection 2022.

Authors

Sunisa Prasopporn^{1

2}, Orawan Suppramote^{2

3}, Ben Ponvilawan², Chanette Jamyuang², Jantappapa Chanthercrob¹, Amphun Chaiboonchoe¹, Pimkanya More-Krong¹, Kamonchanok Kongsri¹, Monthira Suntiparpluacha¹, Rawisak Chanwat⁴, Krittiya Korphaisarn⁵, Seiji Okada⁶, Somponnat Sampattavanich^{1

2}, Siwanon Jirawatnotai^{1

2}

Affiliations

¹ Siriraj Center of Research Excellence for Precision Medicine and Systems Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
² Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
³ Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
⁴ HepatoPancreato-Biliary Surgery Unit, Department of Surgical Oncology, National Cancer Institute, Bangkok, Thailand.
⁵ Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
⁶ Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.1021632.].

Keywords: Gemcitabine plus Cisplatin therapy; LCL161; SMAC mimetics; acquired vulnerability; cholangiocarcinoma; multidrug resistance.

Publication types

Published Erratum

Grants and funding

This study was funded by grants from the National Science and Technology Development Agency (NSTDA) of Thailand, the Japan Science and Technology Agency, and the National Institute of Allergy and Infectious Diseases of the United States as part of the e-ASIA Joint Research Program (e-ASIA JRP); the NSTDA (P-15-50208), the National Research Council of Thailand (NRCT) R016441034, the Advanced Research in Pharmacology Fund, Siriraj Foundation (D003421), and by Mahidol University (Basic Research Fund, and the grant of fiscal year 2022).